Iridex Corporation Revises Full-Year 2026 Revenue Guidance
Alongside its third-quarter 2026 financial results, Iridex Corporation reduced its full-year 2026 revenue guidance to a range of $46 million to $48 million, excluding Middle East revenue. This is a downward revision from the previous guidance range of $51 million to $53 million. The company expects adjusted operating expenses to remain flat between $19 million and $19.5 million for the year. Strategic initiatives to improve profitability include a completed headquarters relocation and an ongoing product line review.